Together Pharma Overview
Valuation check: TGPHF's PEG ratio is 25.44, above the sector sector average of 3.55.
Get informed when a big investor buys or sells
+ Follow25.44
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
The latest PEG ratio for TGPHF is 25.44. That is above the sector sector average of 3.55. Investors often review this figure alongside Together Pharma's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, TGPHF currently prints 25.44 for PEG ratio, while the sector average sits near 3.55. That is roughly 616.7% above the sector mean. Large gaps often invite a closer look at Together Pharma's growth, margins, and balance sheet.
A PEG ratio of 25.44 for Together Pharma is not 'good' or 'bad' on its own. Compare it with the peer average (3.55) and with TGPHF's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting TGPHF's PEG ratio (25.44), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
